As part of the collaboration, BASF will contribute its R&D expertise in catalytic materials and technologies, while Mingyang will focus on applying its research capabilities to Power-to-X equipment.
A recent roundtable discussion featuring Aloka Srinivasan of Raaha, Mayank Bhanti of the United States Pharmacopeia (USP), and Amber Burch of Purisys discussed the challenges surrounding nitrosamine analysis in pharmaceuticals.